These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34725958)

  • 1. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score.
    Chaftari P; Chaftari AM; Hachem R; Yeung SJ; Dagher H; Jiang Y; Malek AE; Dailey Garnes N; Mulanovich VE; Raad I
    Cancer Med; 2021 Dec; 10(23):8475-8482. PubMed ID: 34725958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia.
    Ahn S; Lee YS; Lim KS; Lee JL
    Support Care Cancer; 2013 Aug; 21(8):2303-8. PubMed ID: 23519568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Serum Procalcitonin Levels in Patients With Febrile Neutropenia Presenting to the Emergency Department.
    Yadav S; Mathew R; Sahu AK; Jamshed N; Mohindra R; Aggarwal P; Batra A; Halder D; Brunda RL
    J Emerg Med; 2021 May; 60(5):641-647. PubMed ID: 33518374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department.
    García de Guadiana-Romualdo L; Cerezuela-Fuentes P; Español-Morales I; Esteban-Torrella P; Jiménez-Santos E; Hernando-Holgado A; Albaladejo-Otón MD
    Biochem Med (Zagreb); 2019 Feb; 29(1):010702. PubMed ID: 30591812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia.
    Doerflinger M; Haeusler GM; Li-Wai-Suen CSN; Clark JE; Slavin M; Babl FE; Allaway Z; Mechinaud F; Smyth GK; De Abreu Lourenco R; Phillips B; Pellegrini M; Thursky KA
    Front Immunol; 2021; 12():641879. PubMed ID: 34093531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients.
    Moustafa R; Albouni T; Aziz G
    PLoS One; 2021; 16(7):e0253842. PubMed ID: 34324506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia.
    García de Guadiana-Romualdo L; Jiménez-Santos E; Cerezuela-Fuentes P; Español-Morales I; Berger M; Esteban-Torrella P; Hernando-Holgado A; Albaladejo-Otón MD
    Clin Chem Lab Med; 2019 Mar; 57(4):540-548. PubMed ID: 30240355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
    Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
    Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
    Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
    Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.
    Hemming V; Jakes AD; Shenton G; Phillips B
    BMC Pediatr; 2017 Jan; 17(1):2. PubMed ID: 28056911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of Procalcitonin, lactate, white blood cell count and neutrophil-lymphocyte count ratio to predict blood stream infection. Analysis of a large database.
    Marik PE; Stephenson E
    J Crit Care; 2020 Dec; 60():135-139. PubMed ID: 32799183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic and prognostic value of angiopoietins compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
    Mimaroğlu E; Çıtak EÇ; Kuyucu N; Eskendari G
    Turk J Pediatr; 2017; 59(4):418-425. PubMed ID: 29624222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia.
    Reyes Mondragón AL; Cantú-Rodríguez OG; Garza-Acosta AC; Gutiérrez-Aguirre CH; Colunga Pedraza PR; Del Carmen Tarín-Arzaga L; Jaime-Pérez JC; Hawing Zárate JA; González-Cantú GA; Villalobos-Gutiérrez LE; Jiménez-Castillo RA; Vera-Pineda R; Gómez-Almaguer D
    Blood Cells Mol Dis; 2021 Sep; 90():102586. PubMed ID: 34126299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.
    Srinivasan A; Kumar N; Scott JX
    Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin versus C-Reactive Protein as a Biomarker for Prediction of Bacterial Infection in Children with Febrile Neutropenia in Acute Leukemia.
    Nahar A; Jamal CY; Refat R; Chowdhury T; Akter S; Karim A; Rahman MA; Yeamin MB; Saha BK; Hossain F; Rabbany MA
    Mymensingh Med J; 2023 Jan; 32(1):76-82. PubMed ID: 36594305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients.
    Blouin AG; Hsu M; Fleisher M; Ramanathan LV; Pastores SM
    Clin Chim Acta; 2020 Nov; 510():181-185. PubMed ID: 32679129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of procalcitonin for suspected nosocomial bloodstream infection.
    Cha JK; Kwon KH; Byun SJ; Ryoo SR; Lee JH; Chung JW; Huh HJ; Chae SL; Park SY
    Korean J Intern Med; 2018 Jan; 33(1):176-184. PubMed ID: 29108401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation.
    Michel CS; Teschner D; Wagner EM; Theobald M; Radsak MP
    Ann Hematol; 2017 Dec; 96(12):2095-2101. PubMed ID: 28920169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial.
    Lima SS; Nobre V; de Castro Romanelli RM; Clemente WT; da Silva Bittencourt HN; Melo AC; Salomão LC; Serufo JC
    Ann Hematol; 2016 Jun; 95(7):1169-76. PubMed ID: 27118539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.